The goal in the OR is to optimise fluid and drug therapy prior and during surgery. Successful hemodynamic monitoring in OR reduces the resources need for high-dependency (ICU).
The challenge is managing the unstable patient and the the need is the flexibility to adapt to the acuity of the patient switching seamlessly between non-invasive and minimally invasive hemodynamic monitoring using LiDCOrapid and LiDCOunity, allowing the depth of anesthesia to be measured.
Suitable for a variety of procedures including elected bowel surgery, aortic aneurism, vascular surgery.
Patient Population
High-risk peripheral vascular surgery.
LiDCO Monitor
LiDCOrapid as the hemodynamic part of a multimodal monitoring approach.
Trial Design
Actual mortality after multimodal approach vs predicted V-POSSUM.
Outcome Impact
30-day mortality at 0.8% significantly lower than the 9% mortality predicted by the V-POSSUM amputation rate less than 2% after one year. Post-operatively only 8% (10 patients) went to a high dependency unit (HDU).
Patient Population
High-risk general surgery.
LiDCO Monitor
LiDCOrapid fluid optimisation & oxygen delivery (DO2) GDT target.
Trial Design
Randomised GDT with fluid restriction vs GDT with liberal maintenance fluids.
Outcome Impact
Allowed GDT DO2 targeting while restricting maintenance fluids; reducing expected complications rate from 61.5% to 20%.
Patient Population
OPTIMISE – High-risk gastrointestinal surgery.
LiDCO Monitor
LiDCOrapid guided hemodynamic algorithm with dopexamine infusion vs usual care.
Trial Design
Prospective multi-centre randomised.
Outcome Impact
Lower, compound complications (36.6% v 43.4% n.s.) The inclusion of results in a meta-analysis indicates intervention was associated with a clinically significant lower level of complications.
Find out more about our entire range of hemodynamic monitoring equipment for the Operating Room…
